The Evidence Based Rheumatology Podcast

The Evidence Based Rheumatology Podcast header image 1

E64: Antirheumatic Disease Therapies: A Systematic Review and Meta Analysis

August 27th, 2020

This week I wanted to share a recent systematic review and meta analysis, which was published by myself and a group on behalf of the Global Rheumatology Alliance. I use this as an opportunity to close out a few issues and describe the current landscape.  After this I'm planning to go back to good old rheumatology-based podcasts for a few months! 

E63: Housekeeping #3

August 27th, 2020

The podcast is back!  I tune in briefly here to explain where I've been, what I'm doing, and where this will be headed. Feel free to skip right ahead if you'd rather just dig back in! 

E62: COVID19 Series - Hydroxychloroquine #3

April 14th, 2020

Back this week to update you on the data for hydroxychlorquine.  There has been a lot of action - and very little resolution - to this issue since my last episode.  Let me know what you think, follow along on twitter @ebrheum and get the papers themselves at  

E61: COVID19 Series - IL6 #1

April 2nd, 2020

Diving into a new "rheum treatments for COVID" topic today - IL6 inhibition. It took me awhile to get to this, in part because the hydroxychloroquine situation has been something to behold and in part because there's just nothing to say. I cover two case series here, neither of which are strong evidence. Hope you enjoy! Follow me @ebrheum to let me know what you think! 

E60: COVID19 Series - Hydroxychloroquine #2

March 26th, 2020

Trying to get to IL6, but so much happening in the world of hydroxychloroquine. As I said at the beginning, things are likely to move fast.  I'm planning to make this as an extended series, so please go back and listen to #1 before you listen to this!  This episode will round out the paper by Gautret et al. and discuss the best copy of a paper by Jun et al. that I've been able to find. Follow me @ebrheum and share with friends! 

E59: COVID19 Series - Hydroxychloroquine v1

March 20th, 2020

Welcome to the first episode of my series on immunosuppressive treatments for COVID-19. Today I cover the Renault trial and a nice systematic review, which I believe are the two best options in the published literature to date.  Find the papers and ways to subscribe at and follow me on twitter @ebrheum

E58: Brief Update - Podcasting in the Era of COVID-19

March 19th, 2020

Quick update podcast.  I'm planning to tweak the format of my podcast to better respond to COVID-19.  I'll be doing more or less the same thing but with a different structure and focus.  It seems a little peculiar to discuss anything else during the current crisis, so I intend to refocus and hope to offer value to listeners.  Share with friends - and @ebrheum

E57: PEXIVAS Trial - PLEX and Reduced Steroid in ANCA Vasculitis

February 19th, 2020

PEXIVAS has landed!  This week I go over the trial and my take on it's results.  Impressive undertaking that answered two questions for a subset of patients with AAV - well worth the time to kick back and read the trial in full. Let me know what you think about the podcast @ebrheum! 

E56: Continue or Withdraw Prednisone in SLE (CORTICOLUP)

February 6th, 2020

(Yet) another RCT this week!  Nice investigator initiated trial with many wonderful strengths and a few crippling flaws. Great opportunity to think about a common problem in practice as well as a separate common problem in trials! 

E55: Anifrolumab for SLE (TULIP 1&2)

January 23rd, 2020

This week I talk about the recently published TULIP 1 and TULIP 2 trials that assessed anifrolumab for active SLE.  Great to see a new drug in this disease state; interesting to think through how these trials played out.  Get the papers and the pod at and follow me @ebrheum if you'd like to share feedback! 

Podbean App

Play this podcast on Podbean App